ARROWHEAD PHARMACEUTICALS, INC. Cash Divested from Deconsolidation
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Cash Divested from Deconsolidation of $1.58 million for the 131-month period ending 2014-03-31, per its 10-Q filed 2014-05-06.
Discontinued › Cash Flow › Cash
us-gaap:CashDivestedFromDeconsolidation · last filed 2014-11-25
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for the quarter ending 2012-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for the quarter ending 2012-06-30 was -$21.00K.
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for the quarter ending 2012-03-31 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for the quarter ending 2011-12-31 was -$100.03K.
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for fiscal 2012 was -$121.03K, a 107.12% decline from fiscal 2011.
- ARROWHEAD PHARMACEUTICALS, INC. cash divested from deconsolidation for fiscal 2011 was $1.70M.
| Period end | Cash Divested from Deconsolidation 3 month | Cash Divested from Deconsolidation 6 month | Cash Divested from Deconsolidation 9 month | Cash Divested from Deconsolidation 12 month | Cash Divested from Deconsolidation 98 month | Cash Divested from Deconsolidation 101 month | Cash Divested from Deconsolidation 104 month | Cash Divested from Deconsolidation 107 month | Cash Divested from Deconsolidation 110 month | Cash Divested from Deconsolidation 113 month | Cash Divested from Deconsolidation 116 month | Cash Divested from Deconsolidation 119 month | Cash Divested from Deconsolidation 122 month | Cash Divested from Deconsolidation 125 month | Cash Divested from Deconsolidation 128 month | Cash Divested from Deconsolidation 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $1.58M 10-Q · filed 2014-05-06 | |||||||||||||||
| 2013-12-31 | $1.58M 10-Q · filed 2014-02-04 | |||||||||||||||
| 2013-09-30 | $1.58M 10-K · filed 2013-12-18 | |||||||||||||||
| 2013-06-30 | $1.58M 10-Q · filed 2013-08-07 | |||||||||||||||
| 2013-03-31 | $1.58M 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $1.58M 10-Q · filed 2013-02-13 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | -$21.00K derived: sum of 2 quarters · filed 2014-11-25 | -$21.00K derived: sum of 3 quarters · filed 2014-11-25 | -$121.03K 10-K · filed 2014-11-25 | $1.58M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | -$21.00K derived: sum of 2 quarters · filed 2013-08-07 | -$121.03K 10-Q · filed 2013-08-07 | -$121.03K derived: sum of 4 quarters · filed 2013-08-07 | $1.58M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | -$100.03K 10-Q · filed 2013-05-09 | -$100.03K derived: sum of 3 quarters · filed 2013-05-09 | -$100.03K derived: sum of 4 quarters · filed 2013-05-09 | $1.60M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | -$100.03K 10-Q · filed 2013-02-13 | -$100.03K derived: sum of 2 quarters · filed 2013-02-13 | -$100.03K derived: sum of 3 quarters · filed 2013-02-13 | $1.60M 10-Q · filed 2012-02-09 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $0.00 derived: sum of 2 quarters · filed 2012-12-28 | $1.70M 10-K · filed 2012-12-28 | $1.70M 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | $1.70M 10-Q · filed 2012-08-13 | $1.70M 10-Q · filed 2011-08-08 | |||||||||||||
| 2011-03-31 | $1.70M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |